Viewing Study NCT05737095



Ignite Creation Date: 2024-05-06 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05737095
Status: RECRUITING
Last Update Posted: 2023-02-21
First Post: 2023-02-08

Brief Title: Study of the Feasibility of Early Lung Ultrasound in Neonatal Respiratory Distress in Premature Newborns Born Between 32 Weeks of Amenorrhea and 36 Weeks Plus 6 Days of Amenorrhea Hospitalized in the Neonatal Pediatrics and Intensive Care Units of the Dijon University Hospital
Sponsor: Centre Hospitalier Universitaire Dijon
Organization: Centre Hospitalier Universitaire Dijon

Study Overview

Official Title: Study of the Feasibility of Early Lung Ultrasound in Neonatal Respiratory Distress in Premature Newborns Born Between 32 Weeks of Amenorrhea and 36 Weeks Plus 6 Days of Amenorrhea Hospitalized in the Neonatal Pediatrics and Intensive Care Units of the Dijon University Hospital
Status: RECRUITING
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: REchoPP
Brief Summary: Monocentric study carried out in the Neonatal and Intensive Care Units of the Dijon University Hospital

The objective is to evaluate the feasibility of performing a pulmonary ultrasound within 6 hours after admission in premature infants born between 32 weeks of amenorrhea and 36 weeks of amenorrhea 6 days who are hospitalized for initial respiratory distress

Pulmonary ultrasound is performed within 6 hours of admission and an ultrasound score is calculated according to the images observed

Continued management according to protocols without taking into account the ultrasound data

Follow-up of patients until discharge from hospital or D28 of life whichever comes first
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None